Literature DB >> 15163416

External quality control assessment in PCR diagnostics of dengue virus infections.

Karin Lemmer1, Oliver Donoso Mantke, Hi-Gung Bae, Jan Groen, Christian Drosten, Matthias Niedrig.   

Abstract

BACKGROUND: Increased travelling to countries endemic for dengue fever (DF) demands efficient laboratory diagnostics. Nucleic acid amplification techniques (NAT) are now frequently used for rapid diagnosis of imported viral diseases. Different PCR systems are available.
OBJECTIVES: In order to assess the quality of molecular diagnostics of dengue virus infections, an external quality assurance (EQA) in PCR diagnostics was conducted. STUDY
DESIGN: A panel of 10 human plasma samples was prepared and spiked with dengue virus types DEN-1 to DEN-4. In addition, a 10-fold dilution series (1:10-1:10(4) ) of DEN-3 virus was included. The panel was pre-tested by nested RT-PCR, in-house real-time PCR, and a commercial real-time PCR kit. The samples were inactivated by gamma irradiation and shipped in freeze dried state. Thirteen laboratories, within the European network for the diagnostics of imported viral diseases (ENIVD) took part using either single-round, nested, or real-time RT-PCR methods. Two laboratories used two methods in parallel, summarising up to 15 comparable results.
RESULTS: 33-100% correct results were achieved. All laboratories detected DEN-2 correctly, followed by DEN-1 (14 positive results of 15), DEN-3 (12/15) and DEN-4 (11/15). Testing of the serial dilution revealed low sensitivity in many labs, with results ranging from 33 to 80% of correctly tested samples.
CONCLUSION: The EQA gives a feedback of the quality of the RT-PCR system used by each respective laboratory. The different test systems and amplification conditions demonstrate the importance of external quality control measures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163416     DOI: 10.1016/j.jcv.2003.11.002

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  8 in total

1.  Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes.

Authors:  Menaka D Hapugoda; Gaurav Batra; W Abeyewickreme; S Swaminathan; N Khanna
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

Review 2.  Emerging Pathogens - How Safe is Blood?

Authors:  Michael Schmidt; Wolf-Jochen Geilenkeuser; Walid Sireis; Erhard Seifried; Kai Hourfar
Journal:  Transfus Med Hemother       Date:  2013-12-27       Impact factor: 3.747

3.  Development of multiplex real-time reverse transcriptase PCR assays for detecting eight medically important flaviviruses in mosquitoes.

Authors:  Day-Yu Chao; Brent S Davis; Gwong-Jen J Chang
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

4.  The laboratorial diagnosis of dengue: applications and implications.

Authors:  Nina Rocha Dutra; Marília Barbosa de Paula; Michelle Dias de Oliveira; Leandro Licursi de Oliveira; Sérgio Oliveira De Paula
Journal:  J Glob Infect Dis       Date:  2009-01

5.  2nd International external quality control assessment for the molecular diagnosis of dengue infections.

Authors:  Cristina Domingo; Matthias Niedrig; Anette Teichmann; Marco Kaiser; Leonid Rumer; Richard G Jarman; Oliver Donoso-Mantke
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

6.  Pan-dengue virus detection by PCR for travelers returning from the tropics.

Authors:  Alexis Dumoulin; Hanspeter Marti; Marcus Panning; Christoph Hatz; Hans H Hirsch
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948

7.  First international external quality assessment study on molecular and serological methods for yellow fever diagnosis.

Authors:  Cristina Domingo; Camille Escadafal; Leonid Rumer; Jairo A Méndez; Paquita García; Amadou A Sall; Anette Teichmann; Oliver Donoso-Mantke; Matthias Niedrig
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

8.  Comparative performance study of three Ebola rapid diagnostic tests in Guinea.

Authors:  Zelda Moran; William Rodriguez; Doré Ahmadou; Barré Soropogui; N' Faly Magassouba; Cassandra Kelly-Cirino; Yanis Ben Amor
Journal:  BMC Infect Dis       Date:  2020-09-15       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.